BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹7.22 Cr | ₹7.39 Cr | ₹2.57 Cr | ₹5.61 Cr | ₹4.74 Cr |
What is the latest Consolidated Net Profit of BAL PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹7.22 Cr |
| Mar2024 | ₹7.39 Cr |
| Mar2023 | ₹2.57 Cr |
| Mar2022 | ₹5.61 Cr |
| Mar2021 | ₹4.74 Cr |
How is Consolidated Net Profit of BAL PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.22 Cr | -2.39 | |
| Mar2024 | ₹7.39 Cr | 187.40 | |
| Mar2023 | ₹2.57 Cr | -54.17 | |
| Mar2022 | ₹5.61 Cr | 18.35 | |
| Mar2021 | ₹4.74 Cr | - | |
Compare Consolidated Net Profit of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹106.6 Cr | -4.9% | -9.6% | -41.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -4.9% |
-9.6% |
-41.3% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses